Comparative clinical and molecular outcomes of first, second, and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia: A comprehensive Bayesian network meta-analysis.

Authors
Category Systematic review
ConferenceASCO MEETING ABSTRACTS
Year 2025
This article has no abstract
Epistemonikos ID: 37dcf1a27e77abfb57e91371af2a6d648de00d37
First added on: May 13, 2026